KLAS Research grants Cloudbreak top performance marks; validates favorable outcomes achieved
COLUMBUS, Ohio–(BUSINESS WIRE)–#CloudbreakHealth—Cloudbreak Health, LLC (“Cloudbreak”), a leading telehealth and video remote interpretation solutions provider, today released its KLAS First Look report on Cloudbreak. The industry-recognized report details Cloudbreak’s high performance based on a comprehensive survey of clients who use Cloudbreak telehealth and interpretation solutions.
The KLAS First Look report reveals that Cloudbreak clients:
“Cloudbreak provides a well-designed, reliable, and cost-effective telehealth and virtual language interpretation service for over 250 languages,” said Mike Davis, HCIT market research and analysis expert. “Cloudbreak integrates with telehealth and EHR platforms to provide a seamless experience for including interpretation services during a patient encounter. The solution also supports an easy integration into provider team workflows to improve care quality. Cloudbreak is easily implemented and provides a high level of customer service.”
“The KLAS Research First Look report gives us invaluable objective client feedback to shape the future of Cloudbreak as a mission-critical partner promoting health equity and resolving disparities across the continuum,” said Jamey Edwards, CEO of Cloudbreak Health. “Our core objective is to reliably and easily connect patients and providers wherever they may be, whenever they need it, and in any language they speak. The insights in this report will help us move quickly to improve our solutions as we enhance a seamless user experience that enables the best patient outcomes.”
KLAS Research surveyed individuals from seven unique organizations that use the Cloudbreak telehealth platform. Customer experience areas surveyed include: “Time to See Outcomes” and “Scalability” (where 86% rated as “Easy to scale” or “Scalable with effort”). Customer-validated features and services surveyed include: language interpretation services, specialty consultation, device agnostic, and telequarantine capabilities. Additionally, the report addressed the long-term viability of Cloudbreak, the impacts and tradeoffs of its underlying technology, and considerations around virtual language interpretation and offshore language services.
To learn more about Cloudbreak telehealth and language access solutions for your healthcare system, call (614) 468-6000, email communications@cloudbreak.us, or visit https://cloudbreak.us.
Selected commentary collected about Cloudbreak Health, LLC © 2021 KLAS. Visit klasresearch.com for a complete view.
About Cloudbreak
Cloudbreak Health (www.cloudbreak.us) revolutionized patient and provider communication with the introduction of video remote interpreting (VRI), establishing Cloudbreak as a pioneer in telehealth technology. Cloudbreak continues to innovate with Cloudbreak Telehealth Solutions, including telepsychiatry, telestroke, tele-quarantine, remote patient monitoring and other specialties. Committed to overcoming healthcare disparities and bringing language access to the point of care, Cloudbreak Health seamlessly integrates their language access solution, Martti, into a host of platforms including Epic, Zoom, and Caregility. Performing more than one million minutes of telemedicine consultation each month on over 14,000 video endpoints at 1,800+ healthcare locations nationwide, Cloudbreak Telehealth simplifies how providers care for patients, putting a full care continuum at their fingertips 24/7. Follow Cloudbreak on Twitter @cloudbreakhlth.
About KLAS
KLAS has been providing accurate, honest, and impartial insights for the healthcare IT (HIT) industry since 1996. The KLAS mission is to improve the world’s healthcare by amplifying the voice of providers and payers. The scope of our research is constantly expanding to best fit market needs as technology becomes increasingly sophisticated. KLAS finds the hard-to-get HIT data by building strong relationships with our payer and provider friends in the industry. Learn more at klasresearch.com.
Contacts
Paulo Acuña
310.824.9000
pacuna@olmsteadwlliams.com
Amazfit Active becomes the world's first smartwatch under €200 to fully-integrate AI. MILPITAS, Calif., July…
Investment will support investigation of Mission's small molecule drug MTX325 in patients with early-stage Parkinson's…
New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/…
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the…
Change of Registered AddressLONDON, UK / ACCESSWIRE / July 2, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg'…
GOTHENBURG, SWEDEN / ACCESSWIRE / July 2, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…